LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1626 | 3846 | 0.4229 | 0.3038 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 658 | 605 | 3846 | 0.1574 | -0.0166 |
Hs 578T | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3595 | 3846 | 0.9347 | 0.9212 |
Hs 578T | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 658 | 477 | 3846 | 0.1241 | -0.0567 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 658 | 861 | 3846 | 0.2240 | 0.0638 |
Hs 578T | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3099 | 3846 | 0.8058 | 0.7656 |
Hs 578T | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 658 | 627 | 3846 | 0.1631 | -0.0097 |
Hs 578T | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 658 | 383 | 3846 | 0.0997 | -0.0862 |
Hs 578T | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 658 | 440 | 3846 | 0.1144 | -0.0684 |
Hs 578T | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 658 | 3403 | 3846 | 0.8850 | 0.8612 |
Hs 578T | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3490 | 3846 | 0.9074 | 0.8883 |
Hs 578T | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3422 | 3846 | 0.8898 | 0.8671 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 934 | 3846 | 0.2429 | 0.0866 |
Hs 578T | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 1310 | 3846 | 0.3406 | 0.2045 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 556 | 3846 | 0.1447 | -0.0320 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 540 | 3846 | 0.1405 | -0.0370 |
Hs 578T | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 1204 | 3846 | 0.3131 | 0.1713 |
Hs 578T | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 658 | 4086 | 3846 | 1.0625 | 1.0755 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3616 | 3846 | 0.9402 | 0.9278 |
Hs 578T | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 1085 | 3846 | 0.2821 | 0.1339 |
Hs 578T | R406 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1994 | 3846 | 0.5185 | 0.4190 |
Hs 578T | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 658 | 1874 | 3846 | 0.4873 | 0.3815 |
Hs 578T | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3709 | 3846 | 0.9645 | 0.9572 |
Hs 578T | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 658 | 737 | 3846 | 0.1917 | 0.0248 |
Hs 578T | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 658 | 628 | 3846 | 0.1634 | -0.0094 |